Bionano Genomics (BNGO) Change in Acquisitions & Divestments (2021 - 2026)

Bionano Genomics' Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $54.1 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 6.76% year-over-year to $54.1 million; the TTM figure through Mar 2026 stood at $232.6 million (up 16.57% YoY), while the FY2025 annual figure was $229.1 million, down 25.36% from the prior year.
• Change in Acquisitions & Divestments came in at $54.1 million for Q1 2026 at Bionano Genomics, down from $68.4 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $158.2 million in Q1 2024 to a low of $16.9 million in Q1 2023.
• A 5-year average of $54.6 million and a median of $52.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments surged 836.58% in 2024 and plunged 67.95% in 2025, its largest moves.
• Bionano Genomics' Change in Acquisitions & Divestments stood at $65.5 million in 2022, then retreated by 20.38% to $52.2 million in 2023, then slumped by 58.4% to $21.7 million in 2024, then soared by 215.1% to $68.4 million in 2025, then retreated by 20.82% to $54.1 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $54.1 million, $68.4 million, and $56.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison